The Effect of Feeding with Chironomid and Artemia on Fatty Acids and Amino Acids Profiles in Persian Sturgeon (Acipenser persicus) Larvae

Table 2

Fatty acids profile (%) of whole body of Persian sturgeon (A. persicus) larvae after 11 days feeding with different live foods (mean ± SE; n = 3).

FA				Treatments
				Artemia + Daphnia	Artemia	Artemia + Chironomid	Chironomid
SFA		Lauric	C12 : 0	0.00 ± 0.00	0.00 ± 0.00	0.25 ± 0.02	0.61 ± 0.02
		Myristic	C14 : 0	1.22 ± 0.35^b	1.01 ± 0.33^b	2.78 ± 0.15^a	3.26 ± 0.51^a
		Pentadecanoic	C15 : 0	0.67 ± 0.09^b	0.36 ± 0.15^b	1.28 ± 0.07^a	1.23 ± 0.05^a
		Palmitic	C16 : 0	24.12 ± 0.88	21.65 ± 1.93	18.95 ± 0.28	18.86 ± 0.49
		Heptadecanoic	C17 : 0	1.89 ± 1.05	1.06 ± 0.39	2.68 ± 0.16	2.72 ± 0.05
		Stearic	C18 : 0	12.17 ± 0.45^a	7.50 ± 0.69^b	9.93 ± 0.45^ab	8.98 ± 0.28^b
MUFA		Myristoleic	C14 : 1	0.24 ± 0.04^b	0.44 ± 0.33^ab	1.68 ± 0.15^ab	2.20 ± 0.51^a
		Pentadecenoic	C15 : 1	0.45 ± 0.04^b	0.12 ± 0.05^b	0.51 ± 0.02^a	0.61 ± 0.07^a
		Palmitoleic	C16 : 1	5.62 ± 1.56	7.19 ± 0.93	8.35 ± 0.03	9.11 ± 1.10
		Heptadecenoic	C17 : 1	1.46 ± 0.02	1.29 ± 0.68	3.22 ± 0.14	3.15 ± 0.49
		Eicosenoic	C20 : 1	1.01 ± 0.71	1.18 ± 0.84	1.26 ± 0.89	1.27 ± 0.90
		Docosenoic	C22 : 1	0.30 ± 0.71	0.28 ± 0.83	024 ± 0.89	0.26 ± 0.90
		Oleic (ω9)	C18 : 1n9	28.50 ± 0.97^b	35.37 ± 0.40^a	22.72 ± 0.56^c	22.75 ± 0.10^c
UFA	ω3	Linolenic	C18 : 3n3	1.39 ± 0.05	1.40 ± 0.05	1.60 ± 0.04	1.35 ± 0.13
		Eicosatrienoic	C20 : 3n3	0.08 ± 0.08^b	0.29 ± 0.01^ab	0.42 ± 0.06^a	0.44 ± 0.04^a
		Eicosapentaenoic (EPA)	C20 : 5n3	3.85 ± 0.30^a	2.46 ± 0.02^b	0.84 ± 0.02^c	0.89 ± 0.13^c
		Docosapentaenoic	C22 : 5n3	1.72 ± 0.01^a	0.90 ± 0.08^b	0.63 ± 0.02^ab	0.57 ± 0.08^c
		Docosahexaenoic (DHA)	C22 : 6n3	5.84 ± 0.37^ab	6.75 ± 0.85^a	3.24 ± 0.02^b	3.41 ± 0.63^b
	ω6	Linoleic	C18 : 2n6	4.41 ± 1.42^b	6.76 ± 1.27^ab	11.33 ± 0.66^a	10.72 ± 0.45^a
		γ-Linoleic	C18 : 3n6	0.00 ± 0.00^b	0.53 ± 0.12^b	1.54 ± 0.11^a	1.85 ± 0.14^a
		Octadecatrienoic	C20 : 3n6	0.24 ± 0.06^b	0.31 ± 0.06^b	0.91 ± 0.12^a	0.85 ± 0.00^a
		Arachionic	C20 : 4n6	5.08 ± 0.39^a	2.96 ± 0.38^b	4.76 ± 0.45^ab	4.47 ± 0.18^ab
		Adrenic	C22 : 5n6	0.17 ± 0.04^b	0.21 ± 0.00^b	0.88 ± 0.07^a	0.82 ± 0.13^a
		Docosatetraenoic	C22 : 6n6	0.00 ± 0.00	0.00 ± 0.00	0.00 ± 0.00	0.02 ± 0.02
Total		SFA		40.07 ± 0.85^a	31.58 ± 0.58^d	35.63 ± 1.38^b	35.11 ± 1.35^c
		MUFA		37.17 ± 0.29^b	45.87 ± 1.80^a	37.97 ± 0.89^ab	39.36 ± 1.90^ab
		ω3		12.87 ± 0.43^a	11.80 ± 0.49^b	6.74 ± 0.22^c	6.65 ± 0.24^c
		ω6		9.90 ± 0.48^d	10.75 ± 0.52^c	19.42 ± 0.82^a	18.73 ± 0.77^b
		ω3 + ω6		22.67 ± 0.46^c	22.55 ± 0.50^c	26.16 ± 0.64^a	25.38 ± 0.61^b
		DHA/EPA		1.52 ± 0.02^b	2.75 ± 0.37^a	3.84 ± 0.11^a	3.82 ± 0.13^a
		DHA + EPA		9.69 ± 0.67^a	9.21 ± 0.83^a	4.09 ± 0.01^b	4.30 ± 0.13^b
		n-3/n-6		1.30 ± 0.30^a	1.10 ± 0.10^b	0.35 ± 0.00^c	0.36 ± 0.01^c

Dissimilar letters in each row indicate a significant difference among the treatments ().